Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.

Abstract

The field of cardio-oncology is challenged to address an ever greater spectrum of cardiotoxicity associated with combination chemotherapy, greater dose intensity, extremes of age, and enhanced patient survival which exposes more protracted risk of developing congestive heart failure (CHF). Recent reports of chemotherapy-induced hypertension as a common… (More)
DOI: 10.1007/s12350-013-9707-1

Topics

Cite this paper

@article{Schwartz2013TraditionalAN, title={Traditional and novel methods to assess and prevent chemotherapy-related cardiac dysfunction noninvasively.}, author={Ronald G. Schwartz and Diwakar Jain and Eugene Storozynsky}, journal={Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology}, year={2013}, volume={20 3}, pages={443-64} }